Russian pharmaceutical, biologics and consumer healthcare group.
Established in 2001
Sales: more than USD 500 M
Employed: more than 1100 people
The Group operates in 4 main areas:
1) Research & Development (Biomaterials and biotechnology, aptamers, Nano-platforms);
2) Drugs Manufacturing (Fill & Finish, Primary & secondary packaging);
3) Market access, Sales & Distribution (Hospital/specialty care, Pharmacies, Medical equipment & laboratory diagnostics);
4) Construction & Equipping (Construction and equipping of social infrastructure facilities (institutions, hospitals & clinics).
Group's main advantages:
- Technology transfer, localization of foreign manufacturing on the territory of Russia
- Focus on hospital and reimbursement segment
- Five (5) GMP compliant manufacturing sites (Moscow, Ryazan, Podolsk, Novosibirsk)
- Warehouses with efficient logistics and distribution in compliance with GDP/GSP
- R&D of local drugs, including with cooperation with international companies and universities
- Long-term experience in the field of launch and sales of innovative products
|
|
|
1-10 employees
View all Pharmeco Group employees
|
|
Biotechnology
|
|
1-й Нагатинский проезд, д.10 секция 1, Коломенский проезд, д. 13А, Москва, RU
|
|
2001
|
|
Distribution Of Medicines, R&D Of Novel Drugs, Social Infrastructure Construction, State-Of-Art Manufacturing
|
Lyubov Egorova is the CEO of Pharmeco Group.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.